Balkman Decides J&J Will Pay $572 Million to Oklahoma
J&J will pay the state of Oklahoma $572 million for its contribution to the opioid crisis.
Drugs & Medical Devices
Urban Overdose Deaths are Climbing, According to CDC
Overdose deaths are on the rise in urban areas nationwidei, but declining in Michigan.
Judge Set to Rule on Oklahoma’s Case Against J&J
Judge Balkman will decide Oklahoma’s J&J case next week.
Polster Considers Lawyers Proposal for Consolidated Opioid Litigation
Judge Dan Polster considers a recommended strategy for bring all locales into consolidated litigation.
Amgen’s Enbrel Patents Upheld, Copycat from Novartis Denied
Amgen’s drug patent upheld and Novartis’s copycat version is denied.
California Seeks to Stop Pay-to-delay Generic Drug Agreements
Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra. Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,
Novartis Provided False Data to Win Zolgensma Approval, FDA Says
Novartis manipulated data to win approval for its spinal muscular atrophy treatment.
Connecticut Joins Effort to Investigate JUUL’s Marketing Efforts
Connecticut is joining in on an investigation into JUUL’s marketingn efforts.
Restrictions Placed on One-time Opioid Supplies
The Trump Administration follows the lead of some states and restricts short-term opioid use to seven days.
Know More About Hepatitis C and Medicines Used for Its Treatment
What do you know about Hepatitis C and its treatment? Being an informed patient is helpful to successful outcomes.